61.29
5.45%
-3.53
After Hours:
61.29
Centene Corp stock is traded at $61.29, with a volume of 8.39M.
It is down -5.45% in the last 24 hours and down -0.31% over the past month.
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
See More
Previous Close:
$64.82
Open:
$60.25
24h Volume:
8.39M
Relative Volume:
1.53
Market Cap:
$30.94B
Revenue:
$161.73B
Net Income/Loss:
$3.07B
P/E Ratio:
10.64
EPS:
5.76
Net Cash Flow:
$245.00M
1W Performance:
-5.30%
1M Performance:
-0.31%
6M Performance:
-21.51%
1Y Performance:
-18.72%
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
CNC
Centene Corp
|
61.29 | 30.94B | 161.73B | 3.07B | 245.00M | 5.76 |
UNH
Unitedhealth Group Inc
|
545.45 | 503.68B | 400.28B | 14.41B | 20.71B | 15.50 |
ELV
Elevance Health Inc
|
401.98 | 93.23B | 176.81B | 5.98B | 4.55B | 25.60 |
CI
Cigna Group
|
291.46 | 79.80B | 244.32B | 3.43B | 5.18B | 12.24 |
CVS
Cvs Health Corp
|
56.35 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
HUM
Humana Inc
|
295.53 | 35.59B | 115.01B | 1.36B | -4.34B | 11.29 |
Centene Corp Stock (CNC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Resumed | JP Morgan | Overweight |
Dec-13-24 | Upgrade | UBS | Neutral → Buy |
Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
May-30-24 | Initiated | Robert W. Baird | Neutral |
Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
Mar-06-24 | Initiated | Barclays | Overweight |
Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jun-20-23 | Initiated | UBS | Neutral |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-30-22 | Initiated | Argus | Buy |
Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-28-22 | Resumed | Barclays | Overweight |
Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Resumed | Bernstein | Outperform |
May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-07-22 | Resumed | Barclays | Overweight |
Jan-06-22 | Resumed | JP Morgan | Overweight |
Dec-14-21 | Initiated | Goldman | Neutral |
Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
Dec-13-21 | Reiterated | BofA Securities | Buy |
Dec-13-21 | Reiterated | Credit Suisse | Neutral |
Dec-13-21 | Reiterated | Mizuho | Neutral |
Dec-13-21 | Reiterated | Oppenheimer | Outperform |
Dec-13-21 | Reiterated | Stephens | Overweight |
Dec-13-21 | Reiterated | Truist | Buy |
Dec-13-21 | Reiterated | Wells Fargo | Overweight |
Dec-13-21 | Reiterated | Wolfe Research | Outperform |
Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
Sep-10-21 | Initiated | Cowen | Outperform |
Jul-09-21 | Initiated | Seaport Global Securities | Buy |
May-19-21 | Initiated | Wells Fargo | Overweight |
May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
Mar-10-21 | Initiated | Mizuho | Neutral |
Jan-21-21 | Resumed | Goldman | Neutral |
Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Jul-01-20 | Initiated | SVB Leerink | Outperform |
Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-03-20 | Resumed | Evercore ISI | Outperform |
Jan-28-20 | Reiterated | Bernstein | Outperform |
Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
May-10-19 | Upgrade | Citigroup | Neutral → Buy |
Jan-14-19 | Initiated | Stephens | Overweight |
Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Jul-18-18 | Resumed | Citigroup | Neutral |
Dec-18-17 | Reiterated | Jefferies | Buy |
Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
Jun-07-17 | Initiated | Morgan Stanley | Overweight |
May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-05-17 | Initiated | Deutsche Bank | Buy |
Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
Feb-08-17 | Reiterated | Barclays | Overweight |
Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene Corp (CNC) Q4 2024 Earnings Call Highlights: Strong EPS and Revenue Guidance Boost - Yahoo Finance
Earnings call transcript: Centene Q4 2024 beats EPS forecast, stock dips - MSN
Here's How Much $100 Invested In Centene 20 Years Ago Would Be Worth Today - Benzinga
Centene: Q4 Earnings Snapshot - mySA
Centene Q4 Earnings Beat Estimates on Membership Growth, 2025 View Up - Yahoo Finance
Centene's shares slip on higher Medicaid costs - Reuters
Insurance Firm Centene Sees Q4 Revenue Boost, Sticks To Annual Forecast - Benzinga
Robert W. Baird Increases Centene (NYSE:CNC) Price Target to $71.00 - MarketBeat
Centene posts $3.3B profit for 2024, boosted by Medicare drug plan and Obamacare - The Business Journals
Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance - MarketBeat
Elevance Health, Centene donated to Trump inaugural fund, key lawmakers - Fierce healthcare
(CNC)Analyzing Centene's Short Interest - Benzinga
Centene (CNC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Centene's lower medical costs drive Q4 profit - Modern Healthcare
Centene (NYSE:CNC) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS - MarketBeat
Centene (NYSE:CNC) Beats Expectations in Strong Q4 By Stock Story - Investing.com Canada
Centene Corp (CNC) Q4 Earnings: EPS of $0.56 Beats Estimate, Rev - GuruFocus.com
Mediolanum International Funds Ltd Has $4.68 Million Stock Position in Centene Co. (NYSE:CNC) - MarketBeat
Centene Beats Estimates on Better Controlled Medical Expenses - Bloomberg
Centene: Q4 Earnings Snapshot -February 04, 2025 at 06:20 am EST - Marketscreener.com
Centene reports Q4 earnings beat, raises 2025 revenue outlook - Investing.com
Centene reports Q4 earnings beat, raises 2025 revenue outlook By Investing.com - Investing.com South Africa
Centene earnings beat by $0.29, revenue topped estimates - Investing.com
Chicago Partners Investment Group LLC Takes $570,000 Position in Centene Co. (NYSE:CNC) - MarketBeat
Centene Co. (NYSE:CNC) Shares Bought by Pacer Advisors Inc. - MarketBeat
Centene Co. (NYSE:CNC) Shares Sold by Scharf Investments LLC - MarketBeat
Unlocking Q4 Potential of Centene (CNC): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
OLD National Bancorp IN Sells 4,042 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Osborne Partners Capital Management LLC Purchases 10,515 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene Co. (NYSE:CNC) Shares Sold by Swedbank AB - MarketBeat
Centene Co. (NYSE:CNC) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centene Corporation (CNC): Among the Large-Cap Stocks Insiders Are Buying Recently - Insider Monkey
Centene Co. (NYSE:CNC) Shares Sold by Fifth Third Bancorp - MarketBeat
Centene (CNC) Expected to Announce Earnings on Tuesday - MarketBeat
Centene Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
May 16th Options Now Available For Centene (CNC) - Nasdaq
Washington Capital Management Inc. Buys 5,550 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Forsta AP Fonden Acquires 8,000 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Robeco Institutional Asset Management B.V. Sells 72,302 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Centene Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
See How Centene Corp Ranks Among Analysts' Top Picks With Strong Buyback Activity - Nasdaq
Can Centene's Q4 Earnings Navigate Through Rising Medical Costs? - Yahoo Finance
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Centene (NYSE:CNC) Upgraded to Strong-Buy at StockNews.com - MarketBeat
Compelling Reasons for Investors to Hold on to Centene Stock - MSN
KBC Group NV Purchases 343,559 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Fidelity High Income Fund's Centene Corp(CNC) Holding History - GuruFocus.com
Crossmark Global Holdings Inc. Sells 360,149 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Nisa Investment Advisors LLC Sells 14,649 Shares of Centene Co. (NYSE:CNC) - MarketBeat
Greenlight Capital Added Centene (CNC) on Dip - Yahoo Finance
Merit Financial Group LLC Buys New Shares in Centene Co. (NYSE:CNC) - MarketBeat
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):